INOVIO PHARMACEUTICALS, INC. Payments to Acquire Interest in Subsidiaries and Affiliates
INOVIO PHARMACEUTICALS, INC. (INO) reported Payments to Acquire Interest in Subsidiaries and Affiliates of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates · last filed 2014-03-17
- INOVIO PHARMACEUTICALS, INC. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2011-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2013 was $0.00.
- INOVIO PHARMACEUTICALS, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- INOVIO PHARMACEUTICALS, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2011 was $101.12K.
- INOVIO PHARMACEUTICALS, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2010 was $0.00.
| Period end | Payments to Acquire Interest in Subsidiaries and Affiliates 3 month | Payments to Acquire Interest in Subsidiaries and Affiliates 9 month | Payments to Acquire Interest in Subsidiaries and Affiliates 12 month |
|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-17 | ||
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $101.12K 10-K · filed 2014-03-17 | |
| 2011-09-30 | $101.12K 10-Q · filed 2011-11-07 | ||
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |